{"transactions":[{"id":3168,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2212,"kind":"person","name":"Malzahn Craig","position":1,"cik":"0002062007","reported_name":"Malzahn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-09-03T21:30:23.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":234,"price":9.32,"value":2180.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 1, 2022. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on September 1, 2026."}],"balance_after":81960,"source":{"system":"sec-edgar","filing":"0002062007-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2062007/000206200726000005/primarydocument.xml","form_type":"4"}},{"id":3169,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2213,"kind":"person","name":"Chan Mitchell","position":1,"cik":"0001789335","reported_name":"Chan Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-03T21:29:58.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4902,"price":9.32,"value":45686.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 16, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on September 1, 2026."}],"balance_after":122815,"source":{"system":"sec-edgar","filing":"0001789335-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789335/000178933526000008/primarydocument.xml","form_type":"4"}},{"id":673969,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-25","kind":"grant","planned":false,"acquired":true,"shares":69609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest over a three year period, with 1/3rd of the option vesting on August 25, 2027 and the remaining portion of the option vesting in equal monthly installments over the 24 months thereafter, while the optionee provides continuous service to the Issuer."}],"balance_after":69609,"derivative":{"exercise_price":8.91,"exercise_date":"2027-08-25","expiration_date":"2036-08-25","underlying":"Common Stock","underlying_shares":69609},"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":673968,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":53407,"price":9.356,"value":499675.892,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $9.17 to $9.4525. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":118035,"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":673967,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-26","kind":"purchase","planned":false,"acquired":true,"shares":49196,"price":9.1411,"value":449705.5556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $8.67 to $9.35. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":64628,"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":673966,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-25","kind":"grant","planned":false,"acquired":true,"shares":15432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU).  1/3rd of the shares subject to the RSU award shall vest on each of August 25, 2027, August 25, 2028 and August 25, 2029, while the recipient provides continuous service to the Issuer."}],"balance_after":15432,"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":697197,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-04T20:30:31.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":7468,"price":9.69,"value":72364.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on August 1, 2026."}],"balance_after":205541,"source":{"system":"sec-edgar","filing":"0001700659-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000016/primarydocument.xml","form_type":"4"}},{"id":696939,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-04T20:29:48.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4699,"price":9.69,"value":45533.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on August 1, 2026."}],"balance_after":205968,"source":{"system":"sec-edgar","filing":"0001521123-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000152112326000008/primarydocument.xml","form_type":"4"}},{"id":714710,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:42.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6818,"price":13.09,"value":89247.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on July 1, 2026."}],"balance_after":338053,"source":{"system":"sec-edgar","filing":"0001346164-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000006/primarydocument.xml","form_type":"4"}},{"id":714709,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:42.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1453,"price":10.18,"value":14791.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2026."}],"balance_after":344871,"source":{"system":"sec-edgar","filing":"0001346164-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000006/primarydocument.xml","form_type":"4"}},{"id":714708,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:42.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":951,"price":6.9955,"value":6652.7205,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 1, 2025."}],"balance_after":343418,"source":{"system":"sec-edgar","filing":"0001346164-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000006/primarydocument.xml","form_type":"4"}},{"id":715277,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-07-06T20:51:18.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":2161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 103,698 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 2, 2026, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":64812,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2161},"source":{"system":"sec-edgar","filing":"0001700659-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000014/primarydocument.xml","form_type":"4"}},{"id":715276,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:18.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":2161,"price":13.64,"value":29476.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":213009,"source":{"system":"sec-edgar","filing":"0001700659-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000014/primarydocument.xml","form_type":"4"}},{"id":715275,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:18.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":2161,"price":7.86,"value":16985.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":215170,"source":{"system":"sec-edgar","filing":"0001700659-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000014/primarydocument.xml","form_type":"4"}},{"id":721230,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-07-02T00:08:30.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":36725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 103,698 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 2, 2026, and the balance vests\nin equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer"}],"balance_after":66973,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":36725},"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":721229,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:08:30.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":36725,"price":12.86,"value":472283.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":213009,"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":721228,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:08:30.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":36725,"price":7.86,"value":288658.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":249734,"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":721227,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:08:30.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":19608,"price":11.04,"value":216472.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.00 to $11.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to\nprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213009,"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":754216,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:21:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001502785-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000150278526000001/primarydocument.xml","form_type":"4"}},{"id":754215,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:21:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001502785-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000150278526000001/primarydocument.xml","form_type":"4"}},{"id":754315,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:20:59.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001191235-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000119123526000003/primarydocument.xml","form_type":"4"}},{"id":754314,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:20:59.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001191235-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000119123526000003/primarydocument.xml","form_type":"4"}},{"id":754874,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":10469,"kind":"person","name":"Zachary Jennifer","position":1,"cik":"0001737231","reported_name":"Zachary Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:20:47.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001737231-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737231/000173723126000002/primarydocument.xml","form_type":"4"}},{"id":754873,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":10469,"kind":"person","name":"Zachary Jennifer","position":1,"cik":"0001737231","reported_name":"Zachary Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:20:47.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."}],"balance_after":31871,"source":{"system":"sec-edgar","filing":"0001737231-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737231/000173723126000002/primarydocument.xml","form_type":"4"}},{"id":754741,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:54.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001652824-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000165282426000003/primarydocument.xml","form_type":"4"}},{"id":754740,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:54.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."}],"balance_after":495925,"source":{"system":"sec-edgar","filing":"0001652824-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000165282426000003/primarydocument.xml","form_type":"4"}},{"id":755483,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:41.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001134365-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000113436526000001/primarydocument.xml","form_type":"4"}},{"id":755482,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:41.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001134365-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000113436526000001/primarydocument.xml","form_type":"4"}},{"id":754312,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001191229-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000119122926000002/primarydocument.xml","form_type":"4"}},{"id":754311,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001191229-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000119122926000002/primarydocument.xml","form_type":"4"}},{"id":754745,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001658390-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000165839026000001/primarydocument.xml","form_type":"4"}},{"id":754744,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001658390-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000165839026000001/primarydocument.xml","form_type":"4"}},{"id":754743,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42389,"kind":"person","name":"Fox Allan M.","position":1,"cik":"0001652936","reported_name":"Fox Allan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:15:46.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001652936-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1652936/000165293626000001/primarydocument.xml","form_type":"4"}},{"id":754742,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42389,"kind":"person","name":"Fox Allan M.","position":1,"cik":"0001652936","reported_name":"Fox Allan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:15:46.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001652936-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652936/000165293626000001/primarydocument.xml","form_type":"4"}},{"id":756048,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:15:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001872219-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000187221926000001/primarydocument.xml","form_type":"4"}},{"id":756047,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:15:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001872219-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000187221926000001/primarydocument.xml","form_type":"4"}},{"id":780846,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-13T21:18:54.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":15309,"price":11.02,"value":168705.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.00 to $11.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to\nprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":232617,"source":{"system":"sec-edgar","filing":"0001700659-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000010/primarydocument.xml","form_type":"4"}},{"id":846120,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T22:17:39.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":5124,"price":10.35,"value":53033.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":247926,"source":{"system":"sec-edgar","filing":"0001700659-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000008/primarydocument.xml","form_type":"4"}},{"id":921219,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:47:01.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4700,"price":11.16,"value":52452.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on February 1, 2026."}],"balance_after":210667,"source":{"system":"sec-edgar","filing":"0001521123-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000152112326000006/primarydocument.xml","form_type":"4"}},{"id":921899,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:46:40.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5267,"price":11.16,"value":58779.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on February 1, 2026."}],"balance_after":253050,"source":{"system":"sec-edgar","filing":"0001700659-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000006/primarydocument.xml","form_type":"4"}},{"id":927868,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-29T21:58:46.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":false,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The previously granted option, representing a right to purchase a total of 225,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":225000,"derivative":{"exercise_price":13.09,"expiration_date":"2026-01-28","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001652824-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000165282426000002/primarydocument.xml","form_type":"4"}},{"id":927867,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-29T21:58:46.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":221753,"price":13.41,"value":2973707.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock withheld to satisfy the exercise price and pay taxes upon the exercise of options originally granted to the reporting person on January 28, 2016, which were set to expire on January 28, 2026. The number of shares withheld was determined based on the closing price of the issuer's common stock on January 27, 2026. The transaction did not involve any open-market sale of securities."}],"balance_after":486118,"source":{"system":"sec-edgar","filing":"0001652824-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000165282426000002/primarydocument.xml","form_type":"4"}},{"id":927866,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-29T21:58:46.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":225000,"price":13.09,"value":2945250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The previously granted option, representing a right to purchase a total of 225,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":707871,"source":{"system":"sec-edgar","filing":"0001652824-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000165282426000002/primarydocument.xml","form_type":"4"}},{"id":943251,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T21:44:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":35402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer."}],"balance_after":35402,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":35402},"source":{"system":"sec-edgar","filing":"0001700659-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000004/primarydocument.xml","form_type":"4"}},{"id":943250,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-08T21:44:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":65847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":258317,"source":{"system":"sec-edgar","filing":"0001700659-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000004/primarydocument.xml","form_type":"4"}},{"id":943086,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T21:43:19.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":233651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer."}],"balance_after":233651,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":233651},"source":{"system":"sec-edgar","filing":"0001346164-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000004/primarydocument.xml","form_type":"4"}},{"id":943085,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T21:43:19.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":144864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":342467,"source":{"system":"sec-edgar","filing":"0001346164-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000004/primarydocument.xml","form_type":"4"}},{"id":943068,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Legal Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T21:39:48.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":39650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer."}],"balance_after":39650,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":39650},"source":{"system":"sec-edgar","filing":"0001521123-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000152112326000004/primarydocument.xml","form_type":"4"}},{"id":943067,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-08T21:39:48.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":73749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":215367,"source":{"system":"sec-edgar","filing":"0001521123-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000152112326000004/primarydocument.xml","form_type":"4"}},{"id":942987,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2213,"kind":"person","name":"Chan Mitchell","position":1,"cik":"0001789335","reported_name":"Chan Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T21:33:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":39650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while\nthe optionee provides continuous service to the Issuer."}],"balance_after":39650,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":39650},"source":{"system":"sec-edgar","filing":"0001789335-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590877/000178933526000002/primarydocument.xml","form_type":"4"}},{"id":942986,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2213,"kind":"person","name":"Chan Mitchell","position":1,"cik":"0001789335","reported_name":"Chan Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-08T21:33:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":73749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and\nJanuary 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":127717,"source":{"system":"sec-edgar","filing":"0001789335-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590877/000178933526000002/primarydocument.xml","form_type":"4"}},{"id":943443,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2212,"kind":"person","name":"Malzahn Craig","position":1,"cik":"0002062007","reported_name":"Malzahn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T16:43:48.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":35402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer."}],"balance_after":35402,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":35402},"source":{"system":"sec-edgar","filing":"0002062007-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2062007/000206200726000003/primarydocument.xml","form_type":"4"}},{"id":943442,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2212,"kind":"person","name":"Malzahn Craig","position":1,"cik":"0002062007","reported_name":"Malzahn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-01-08T16:43:48.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":65847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":82194,"source":{"system":"sec-edgar","filing":"0002062007-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2062007/000206200726000003/primarydocument.xml","form_type":"4"}},{"id":945894,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:32:27.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":18559,"price":14.4,"value":267249.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025."}],"balance_after":197603,"source":{"system":"sec-edgar","filing":"0001346164-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000002/primarydocument.xml","form_type":"4"}},{"id":945811,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:31:23.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9793,"price":14.4,"value":141019.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025."}],"balance_after":141618,"source":{"system":"sec-edgar","filing":"0001521123-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000152112326000002/primarydocument.xml","form_type":"4"}},{"id":946818,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:31:06.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":18247,"price":14.4,"value":262756.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025."}],"balance_after":192470,"source":{"system":"sec-edgar","filing":"0001700659-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000003/primarydocument.xml","form_type":"4"}},{"id":947435,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2212,"kind":"person","name":"Malzahn Craig","position":1,"cik":"0002062007","reported_name":"Malzahn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-01-06T16:31:46.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1238,"price":14.4,"value":17827.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, and January 2, 2024. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025."}],"balance_after":16347,"source":{"system":"sec-edgar","filing":"0002062007-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2062007/000206200726000002/primarydocument.xml","form_type":"4"}},{"id":1019988,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-10T22:38:07.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":20811,"price":12.62,"value":262634.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.50 to $12.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":216162,"source":{"system":"sec-edgar","filing":"0001346164-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616425000005/primarydocument.xml","form_type":"4"}},{"id":1029112,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-01T21:02:14.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":7624,"price":10.03,"value":76468.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.00 to $10.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":236973,"source":{"system":"sec-edgar","filing":"0001346164-25-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616425000003/primarydocument.xml","form_type":"4"}},{"id":1041307,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:30:45.000Z","date":"2025-09-10","kind":"sale","planned":true,"acquired":false,"shares":7734,"price":10.02,"value":77494.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.00 to $10.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":244597,"source":{"system":"sec-edgar","filing":"0001562180-25-006194","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025006194/primarydocument.xml","form_type":"4"}},{"id":1049189,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2213,"kind":"person","name":"Chan Mitchell","position":1,"cik":"0001789335","reported_name":"Chan Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-03T20:47:46.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4901,"price":8.93,"value":43765.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 16, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 29, 2025."}],"balance_after":53968,"source":{"system":"sec-edgar","filing":"0001562180-25-006078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590877/000156218025006078/primarydocument.xml","form_type":"4"}},{"id":1050190,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2212,"kind":"person","name":"Malzahn Craig","position":1,"cik":"0002062007","reported_name":"Malzahn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-03T16:49:06.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":234,"price":8.93,"value":2089.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 1, 2022. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 29, 2025."}],"balance_after":17585,"source":{"system":"sec-edgar","filing":"0001562180-25-006079","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2062007/000156218025006079/primarydocument.xml","form_type":"4"}},{"id":1076076,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Legal Officer"}}],"security":"Common Stock","published_at":"2025-08-04T21:17:06.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4699,"price":8.19,"value":38484.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on August 1, 2025."}],"balance_after":151411,"source":{"system":"sec-edgar","filing":"0001562180-25-005618","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000156218025005618/primarydocument.xml","form_type":"4"}},{"id":1092019,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-03T22:53:52.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4701,"price":8.23,"value":38689.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on July 1, 2025."}],"balance_after":252331,"source":{"system":"sec-edgar","filing":"0001562180-25-005334","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025005334/primarydocument.xml","form_type":"4"}},{"id":1124965,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42389,"kind":"person","name":"Fox Allan M.","position":1,"cik":"0001652936","reported_name":"Fox Allan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:37:11.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004355","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1652936/000156218025004355/primarydocument.xml","form_type":"4"}},{"id":1124964,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42389,"kind":"person","name":"Fox Allan M.","position":1,"cik":"0001652936","reported_name":"Fox Allan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:37:11.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004355","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652936/000156218025004355/primarydocument.xml","form_type":"4"}},{"id":1125135,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":10469,"kind":"person","name":"Zachary Jennifer","position":1,"cik":"0001737231","reported_name":"Zachary Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:33:55.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004354","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737231/000156218025004354/primarydocument.xml","form_type":"4"}},{"id":1125134,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":10469,"kind":"person","name":"Zachary Jennifer","position":1,"cik":"0001737231","reported_name":"Zachary Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:33:55.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":22064,"source":{"system":"sec-edgar","filing":"0001562180-25-004354","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737231/000156218025004354/primarydocument.xml","form_type":"4"}},{"id":1124382,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:33:32.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004353","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218025004353/primarydocument.xml","form_type":"4"}},{"id":1124381,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:33:32.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004353","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218025004353/primarydocument.xml","form_type":"4"}},{"id":1124520,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:33:07.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004352","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218025004352/primarydocument.xml","form_type":"4"}},{"id":1124519,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:33:07.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004352","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218025004352/primarydocument.xml","form_type":"4"}},{"id":1124963,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:32:36.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004351","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025004351/primarydocument.xml","form_type":"4"}},{"id":1124962,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:32:36.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":482871,"source":{"system":"sec-edgar","filing":"0001562180-25-004351","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025004351/primarydocument.xml","form_type":"4"}},{"id":1125705,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:32:14.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004350","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218025004350/primarydocument.xml","form_type":"4"}},{"id":1125704,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:32:14.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004350","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218025004350/primarydocument.xml","form_type":"4"}},{"id":1124967,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:32:00.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004349","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218025004349/primarydocument.xml","form_type":"4"}},{"id":1124966,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:32:00.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004349","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218025004349/primarydocument.xml","form_type":"4"}},{"id":1124518,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:31:46.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004348","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218025004348/primarydocument.xml","form_type":"4"}},{"id":1124517,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:31:46.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218025004348/primarydocument.xml","form_type":"4"}},{"id":1126389,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:31:15.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004347","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000156218025004347/primarydocument.xml","form_type":"4"}},{"id":1126388,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:31:15.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004347","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000156218025004347/primarydocument.xml","form_type":"4"}},{"id":1149208,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-14T20:49:12.000Z","date":"2025-05-12","kind":"exercise","planned":true,"acquired":false,"shares":20602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2025-05-19","underlying":"Common Stock","underlying_shares":20602},"source":{"system":"sec-edgar","filing":"0001562180-25-003822","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025003822/primarydocument.xml","form_type":"4"}},{"id":1149207,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T20:49:12.000Z","date":"2025-05-12","kind":"sale","planned":true,"acquired":false,"shares":20602,"price":7.9141,"value":163046.2882,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.66 to $8.04. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":475103,"source":{"system":"sec-edgar","filing":"0001562180-25-003822","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025003822/primarydocument.xml","form_type":"4"}},{"id":1149206,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T20:49:12.000Z","date":"2025-05-12","kind":"exercise","planned":true,"acquired":true,"shares":20602,"price":3.76,"value":77463.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":495705,"source":{"system":"sec-edgar","filing":"0001562180-25-003822","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025003822/primarydocument.xml","form_type":"4"}},{"id":1177430,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-04T21:17:19.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4700,"price":8.07,"value":37929.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025."}],"balance_after":156110,"source":{"system":"sec-edgar","filing":"0001562180-25-003010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000156218025003010/primarydocument.xml","form_type":"4"}},{"id":1177657,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-04T21:17:02.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5263,"price":8.07,"value":42472.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025"}],"balance_after":210717,"source":{"system":"sec-edgar","filing":"0001562180-25-003009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025003009/primarydocument.xml","form_type":"4"}},{"id":1177656,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":81049,"kind":"person","name":"Danos Olivier","position":1,"cik":"0001701180","reported_name":"Danos Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-04-04T17:16:46.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5452,"price":8.07,"value":43997.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025."}],"balance_after":226348,"source":{"system":"sec-edgar","filing":"0001562180-25-003008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701180/000156218025003008/primarydocument.xml","form_type":"4"}},{"id":1187939,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-03-31T21:05:18.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":false,"shares":30752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance\nvested in equal monthly installments over the 36 months thereafter."}],"balance_after":20602,"derivative":{"exercise_price":3.76,"expiration_date":"2025-05-19","underlying":"Common Stock","underlying_shares":30752},"source":{"system":"sec-edgar","filing":"0001562180-25-002804","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025002804/primarydocument.xml","form_type":"4"}},{"id":1187938,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42388,"kind":"person","name":"Mills Kenneth T.","position":1,"cik":"0001652824","reported_name":"Mills Kenneth T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-31T21:05:18.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":true,"shares":30752,"price":3.76,"value":115627.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance\nvested in equal monthly installments over the 36 months thereafter."}],"balance_after":475103,"source":{"system":"sec-edgar","filing":"0001562180-25-002804","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652824/000156218025002804/primarydocument.xml","form_type":"4"}},{"id":1303237,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-14T22:19:54.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":478606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while\nthe optionee provides continuous service to the Issuer."}],"balance_after":478606,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":478606},"source":{"system":"sec-edgar","filing":"0001562180-25-000360","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000360/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-01-06"}},{"id":1310750,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-06T21:59:39.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":103698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer."}],"balance_after":103698,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":103698},"source":{"system":"sec-edgar","filing":"0001562180-25-000190","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025000190/primarydocument.xml","form_type":"4"}},{"id":1310749,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:39.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":64293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer."}],"balance_after":215980,"source":{"system":"sec-edgar","filing":"0001562180-25-000190","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025000190/primarydocument.xml","form_type":"4"}},{"id":1310748,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:39.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":13891,"price":7.73,"value":107377.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024."}],"balance_after":151687,"source":{"system":"sec-edgar","filing":"0001562180-25-000190","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025000190/primarydocument.xml","form_type":"4"}},{"id":1309901,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-06T21:59:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":476606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer."}],"balance_after":476606,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":476606},"source":{"system":"sec-edgar","filing":"0001562180-25-000188","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000188/primarydocument.xml","form_type":"4"}},{"id":1309900,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":98912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer."}],"balance_after":257032,"source":{"system":"sec-edgar","filing":"0001562180-25-000188","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000188/primarydocument.xml","form_type":"4"}},{"id":1309899,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:22.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":11917,"price":7.73,"value":92118.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024."}],"balance_after":158120,"source":{"system":"sec-edgar","filing":"0001562180-25-000188","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000188/primarydocument.xml","form_type":"4"}},{"id":1309732,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":2213,"kind":"person","name":"Chan Mitchell","position":1,"cik":"0001789335","reported_name":"Chan Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-06T21:59:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":62547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer."}],"balance_after":62547,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":62547},"source":{"system":"sec-edgar","filing":"0001562180-25-000187","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590877/000156218025000187/primarydocument.xml","form_type":"4"}},{"id":1309810,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-06T21:59:08.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":223350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer."}],"balance_after":223350,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":223350},"source":{"system":"sec-edgar","filing":"0001562180-25-000186","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000156218025000186/primarydocument.xml","form_type":"4"}},{"id":1309809,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26578,"kind":"person","name":"Christmas Patrick J.","position":1,"cik":"0001521123","reported_name":"Christmas Patrick J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:08.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":11395,"price":7.73,"value":88083.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024."}],"balance_after":160810,"source":{"system":"sec-edgar","filing":"0001562180-25-000186","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521123/000156218025000186/primarydocument.xml","form_type":"4"}}],"next_cursor":"2025-01-06T21:59:08.000000Z,1309809"}